HCA Healthcare (NYSE:HCA – Rating Received) was downgraded to a “buy” rating from a “strong buy” rating by analysts at StockNews.com in a research note published on Thursday.
A number of other research analysts have also commented on HCA. BMO Capital Markets lowered HCA Healthcare to an underperform rating from a market perform rating and lowered its price target on the company to $160.00 from $233.00 in a research report on Wednesday, July 6 $. Stephens raised his target price on HCA Healthcare to $230.00 in a research report on Monday, July 25. Mizuho raised its price target on HCA Healthcare to $230.00 from $210.00 and gave the stock a “buy” rating in a research report on Tuesday, August 2. Credit Suisse Group raised its target price on HCA Healthcare to $250.00 from $230.00 and gave the stock a “Outperform” rating in a research report on Monday, July 25. Finally, Truist Financial raised its target price on HCA Healthcare to $240.00 from $208.00 and gave the stock a “buy” rating in a research report on Monday, July 25. One investment analyst has rated the stock with a sell rating, three with a hold rating and sixteen with a buy rating. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $239.14.
HCA Healthcare stock performance
HCA Healthcare shares fell $4.78 during Thursday trading to hit $194.06. The company had a trading volume of 1,071,820 shares compared to its average volume of 1,751,495. HCA Healthcare has a 52-week low of $164.47 and a 52-week high of $279.02. The company’s 50-day simple moving average is $205.76 and its 200-day simple moving average is $214.90. The company has a market cap of $55.70 billion, a price-to-earnings ratio of 9.33, a price-to-earnings-to-growth ratio of 1.53 and a beta of 1.72. The company has a current ratio of 1.55, a quick ratio of 1.32 and a debt to equity ratio of 87.46.
HCA Healthcare (NYSE:HCA – Get Rating) last announced its earnings results on Friday, July 22nd. The company reported $4.21 per share for the quarter, beating analysts’ consensus estimate of $3.67 by $0.54. HCA Healthcare had a return on equity of 833.68% and a net margin of 10.83%. The company made $14.82 billion in revenue for the quarter, compared to analysts’ expectations of $14.73 billion. In the same period last year, the company earned $4.37 per share. HCA Healthcare revenue for the quarter increased 2.7% compared to the same quarter last year. Sell-side analysts are forecasting that HCA Healthcare will report earnings per share of 17.09 for the current fiscal year.
Insider activity at HCA Healthcare
In other HCA Healthcare news, major shareholder Patricia F. Elcan acquired 325 shares of the company’s shares in a transaction that took place on Monday, July 25th. The shares were purchased at an average price of $198.66 per share for a total value of $64,564.50. Upon completion of the acquisition, the insider now directly owns 89,337 shares of the company’s stock valued at approximately $17,747,688.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission available at this link. 1.50% of the shares are currently owned by company insiders.
Hedge funds rely on HCA Healthcare
Institutional investors and hedge funds have recently bought and sold shares in the company. GoalVest Advisory LLC acquired a new position in HCA Healthcare valued at $26,000 during the first quarter. Wolff Wiese Magana LLC increased its ownership of HCA Healthcare stock by 1,833.3% during the first quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock valued at $29,000 after purchasing an additional 110 shares last quarter. San Luis Wealth Advisors LLC acquired a new stake in HCA Healthcare stock valued at $35,000 during the first quarter. Covestor Ltd increased its position in HCA Healthcare by 122.7% in the first quarter. Covestor Ltd now owns 167 shares of the company, valued at $42,000, having purchased a further 92 shares during the period. Finally, Riverview Trust Co acquired a new $45,000 position in HCA Healthcare during the first quarter. 65.75% of the shares are owned by hedge funds and other institutional investors.
Company profile of HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides healthcare service businesses in the United States. The Company operates general and acute care hospitals that provide medical and surgical services, including inpatient, critical care, cardiac, diagnostic and emergency services; and outpatient services such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
This instant news alert was generated by MarketBeat’s narrative science technology and financial data to provide readers with the fastest, most accurate reporting. This story was reviewed by the MarketBeat editorial team prior to publication. Please send questions or comments about this story to [email protected]
Hear this before you consider HCA Healthcare.
MarketBeat tracks Wall Street’s best-in-class, top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now, before the broader market takes hold… and HCA Healthcare wasn’t on the list.
While HCA Healthcare is currently rated a “Moderate Buy” by analysts, top analysts believe these five stocks are better buys.
Check out the five stocks here